Personalis, Inc. Receives Accreditation from College of American Pathologists (CAP)

CAP Accreditation Is Awarded to Clinical Laboratories Meeting the Highest Standards in Quality Laboratory Practices.

April 23, 2014 – Personalis, Inc., a leading provider of genome-based diagnostics, announced today that its onsite clinical laboratory has received accreditation from the College of American Pathologists (CAP), meeting the highest standard of excellence in clinical laboratory practices. With this accreditation, Personalis, Inc. joins an elite group of globally recognized facilities that operate at the highest level of quality laboratory standards.

The CAP Laboratory Accreditation Program is a globally recognized program that utilizes teams of highly specialized laboratory professionals as inspectors. During the accreditation process, inspectors meticulously examine the clinical laboratory’s records and quality control procedures. They also assess the laboratory’s staff qualifications, equipment, facilities, safety program, and overall management to ensure it meets CAP’s diverse and stringent requirements. The goal of the CAP program is to improve patient safety by advancing the quality of pathology and laboratory services through education and strict standards.

“We strive to provide quality service in every aspect of what we deliver to our customers,” said John West, Personalis’ CEO. “We feel that holding ourselves to the highest standards of laboratory practice is an integral part of our operations. With services such as our ACE Clinical Exome, we are trying to find answers to the most difficult clinical cases. We are committed to providing the most accurate and thorough results possible to our customers, so they can provide the best possible care for their patients.”

About the College of American Pathologists

The College of American Pathologists (CAP), celebrating 50 years as the gold standard in laboratory accreditation, is a medical society that serves more than 18,000 physician members and the global laboratory community. It is the world’s largest association composed exclusively of board-certified pathologists and is the worldwide leader in laboratory quality assurance. The College advocates accountable, high-quality, and cost-effective patient care.

More information about the CAP can be found at

About Personalis, Inc.

Personalis, Inc. ( is a leading precision medicine company focused on advanced NGS-based clinical diagnostic, clinical trial and research services for cancer and inherited genetic disease.  Personalis also provides DNA sequencing and data analysis of human genomes.

The Personalis ACE Exome and Transcriptome technology is designed to obtain the most comprehensive and accurate tumor molecular profile for immuno-oncology applications. The company’s clinical laboratory is GCP compliant, CLIA licensed and CAP accredited.

Media Contact for Personalis:

Jennifer Havlek